FDA approves 1st Tylenol pain relief combination

The FDA has greenlit Kenvue's new Tylenol with Naproxen, marking the first over-the-counter combo of acetaminophen and naproxen sodium to hit the market. This new product offers a potent pain relief option, combining 650 mg of acetaminophen with 220 mg of naproxen sodium in a single pill. This approval not only provides consumers with a more powerful pain relief alternative but also underscores the FDA's commitment to expanding accessible medication options for common ailments. The approval also grants Kenvue a three-year exclusive market period, highlighting the significance and demand for such innovative pain relief solutions.